13 May 2025 (58 Days) Date | | - Cons. EPS | - EPS |
31 Mar 2025 (15 Days) Date | | - Cons. EPS | - EPS |
13 Nov 2024 Date | | - Cons. EPS | - EPS |
12 Nov 2024 Date | | - Cons. EPS | - EPS |
13 Aug 2024 Date | | - Cons. EPS | - EPS |
13 May 2025 (58 Days) Date | | - Cons. EPS | - EPS |
31 Mar 2025 (15 Days) Date | | - Cons. EPS | - EPS |
13 Nov 2024 Date | | - Cons. EPS | - EPS |
12 Nov 2024 Date | | - Cons. EPS | - EPS |
13 Aug 2024 Date | | - Cons. EPS | - EPS |
Medical Devices Industry | Healthcare Sector | Dr. Hemanth Jacob Varghese CFA, Ph.D. CEO | NASDAQ (CM) Exchange | US92332W1053 ISIN |
US Country | 304 Employees | - Last Dividend | 12 May 2023 Last Split | 5 Nov 2012 IPO Date |